指南与共识乳腺CTMRUSDR

ACR适宜性标准®:I期乳腺癌

ACR Appropriateness Criteria® Stage I Breast Carcinoma.
PubMed 文献 · J Am Coll Radiol · 2016-01-01

I期乳腺癌指浸润性癌直径≤2 cm(T1)、无区域(腋窝)淋巴结转移(N0)且无远处转移(M0)。本文为ACR基于证据的适宜性标准,由多学科专家组每2年评审一次,采用改良Delphi共识方法对影像与治疗流程的适宜性进行评分;原文指出对I期乳腺癌诊断后强化筛查与监测相比不强化者无生存或生活质量差异。

要点

  • I期乳腺癌定义为浸润性癌≤2 cm(T1)、无腋窝淋巴结转移(N0)、无远处转移(M0)。
  • 原文指出强化筛查与监测相比不强化者无生存或生活质量差异。
  • PET/CT能否替代现有影像技术尚不确定。

核心结论

  • 对I期乳腺癌诊断后强化筛查与监测相比不强化者无生存或生活质量差异。
  • PET/CT能否替代现有影像技术尚不确定。

研究设计与样本

  • ACR适宜性标准为基于证据的指南,针对特定临床情况由多学科专家组每2年评审一次。
  • 指南制定与评审包括对同行评议期刊当前医学文献的广泛分析,并采用改良Delphi共识方法对影像与治疗流程的适宜性进行评分。
  • 证据缺乏或不确定时,可采用专家意见推荐影像或治疗。

诊断标准与关键数值

  • I期乳腺癌分类标准:浸润性乳腺癌直径≤2 cm(T1),无区域(腋窝)淋巴结转移(N0),无远处转移(M0)。
  • 乳腺癌最常见转移部位为骨骼、肺、肝和脑。

临床应用与阅片要点

  • 筛查方案包括胸部X线摄影、骨扫描、肝脏超声和脑MRI等常规影像。
  • 原文指出对I期乳腺癌诊断后强化筛查与监测相比不强化者无生存或生活质量差异。
  • 原文指出PET/CT能否替代现有影像技术尚不确定。

局限性

  • 证据缺乏或不确定时,可采用专家意见推荐影像或治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Stage I breast carcinoma is classified when an invasive breast carcinoma is ≤2 cm in diameter (T1), with no regional (axillary) lymph node metastases (N0) and no distant metastases (M0). The most common sites for metastases from breast cancer are the skeleton, lung, liver, and brain. In general, women and health care professionals prefer intensive screening and surveillance after a diagnosis of breast cancer. Screening protocols include conventional imaging such as chest radiography, bone scan, ultrasound of the liver, and MRI of brain. It is uncertain whether PET/CT will serve as a replacement for current imaging technologies. However, there are no survival or quality-of-life differences for women who undergo intensive screening and surveillance after a diagnosis of stage I breast carcinoma compared with those who do not. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Huynh PT, Lemeshko SV, Mahoney MC, et al. ACR Appropriateness Criteria® Stage I Breast Carcinoma. J Am Coll Radiol. 2016. PMID: 27814824. doi:10.1016/j.jacr.2016.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。